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Hyperplasia of synovial lining cells and fibroblasts is an early and characteristic 
feature of the synovitis associated with rheumatoid arthritis. The synovial fibro- 
blast hyperplasia contributes to the excessive levels of collagenase and prosta- 
glandins generated in synovitis (1), which likely mediate connective tissue destruc- 
tion. The mechanisms underlying this hyperplastic response are not known, but 
are important to an understanding of the tissue injury in rheumatoid arthritis. 
Associated with this excessive proliferation of synovial fibroblasts  is a  marked 
influx  of mononuclear cells,  including  lymphocytes and  monocytes,  into  the 
sublining areas (2, 3). Based on recent in vitro evidence that human lymphocytes 
and  monocytes can  modulate  fibroblast  growth  (4-9),  it  was  of considerable 
interest to determine whether these cells might be involved in regulating expan- 
sion of the fibroblast population in chronic rheumatoid synovitis. T  lymphocytes, 
which are rarely found in the normal human synovial tissue, are found in large 
numbers, in close apposition to macrophages, in the synovial membrane during 
chronic synovitis. These observations favor cell-mediated immune mechanisms 
in the pathogenesis of this condition. The proximity and concurrent presence of 
activated T  lymphocytes and macrophages with proliferating synovial lining cells 
and fibroblasts also suggests a  role for these mononuclear cells in inducing the 
hyperproliferative response of the synovial cells. 
In this study, synovial fluid and/or synovial tissue were obtained from rheu- 
matoid arthritis  patients  at  knee  arthroscopy.  The  synovial  lymphocytes and 
monocytes were then isolated and the ability of these cells to generate mediators 
of fibroblast  growth  was  analyzed.  These  inflammatory  cells  were  found  to 
spontaneously release fibroblast growth factors that are similar to those previ- 
ously described as products of peripheral blood mononuclear cells after in vitro 
stimulation (4, 6). Synovial tissues obtained from patients with noninflammatory 
.joint disease were not a source of flbroblast growth factors. 
Materials and Methods 
Synovial  Tissue  Collection and Immunohistopathology.  Synovial tissue was  obtained at 
arthroscopy from multiple sites in inflamed knees from 12 patients with confirmed definite 
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or classic rheumatoid arthritis (10). Synovial tissue was also obtained from four individuals 
with noninflammatory  joint disease, including trauma and degenerative joint disease, who 
were undergoing corrective surgery. After removal from the joint, the tissue was washed 
in phosphate-buffered saline (PBS) ~  (pH 7.2, NIH Media Unit). Tissue aliquots were snap- 
frozen in a glycerol base embedding medium (Tissue-Tek II, O.C.T. compound; Miles 
Laboratories, Lab-Tek Div., Naperville, IL) by immersion in a  mixture of dry ice and 
acetone,  or fixed in  10%  phosphate buffered formalin.  Formalin-fixed tissue was em- 
bedded in paraffin, sectioned, and stained with hematoxylin and eosin. 
8-#m sections were cut from the frozen blocks on a cryostat at -20°C (model CTI; 
International Equipment Company, Needham Heights, MA), placed on glass slides,  and 
fixed in acetone (3). Cell surface markers were demonstrated in situ by immunoperoxidase 
staining (11,  12) (ABC Vecta Stain Kit; Vector Laboratories, Burlingame, CA) using the 
monoclonal  antibodies  Leu-l,  a  pan-T  lymphocyte marker;  Leu-2A,  a  "suppressor/ 
cytotoxic" subset marker; Leu-3A, a  "helper/inducer" subset marker; Leu-M1 and Leu- 
M3, monocyte/macrophage markers; anti-HLA-DR (Becton, Dickinson & Co., Sunnyvale, 
CA); and OKM I, a  monocyte/macrophage, natural killer, and null cell marker (Ortho 
Diagnostic Systems, Inc., Westwood, MA). Sections were counterstained with 2% methyl 
green,  dehydrated,  and  mounted  in  Permount  (Fisher  Scientific  Co.,  Fair  Lawn,  N  J) 
under a glass coverslip. Control sections were treated with mouse ascites fluid or normal 
mouse IgG, or were stained in the absence of the primary antibody. 
Synovial  Tissue  Culture and Mononuclear  Cell Isolation.  In addition to specimens for 
immunohistopathology, 250 mg of the synovial tissue were aseptically minced and resus- 
pended  in  10  ml Dulbecco's modified Eagle's medium (DMEM)  (HEM  Research Inc., 
Rockville,  MD)  containing  100  U/ml  penicillin,  100  #g]ml  streptomycin, and  2  mM 
glutamine without serum. The cultures were incubated at 37 °C for varying time periods 
and the supernatants collected and frozen at -20°C. 
To isolate the mononuclear cells from the diseased synovial tissue, portions of minced 
synovial tissue were placed in a spinner flask containing collagenase (3.5 mg/mi; Worthing- 
ton Biochemical Corp., Freehold, NJ) in DMEM and stirred for 20-30 rain at 37°C. The 
cells in suspension were removed, the procedure repeated two to four times, and the 
remaining particulate tissue removed by passage through sterile gauze. The cell suspen- 
sions were pooled, centrifuged, and washed several times and resuspended in PBS. These 
cells were then centrifuged on Ficoll-Paque gradients (Pharmacia, Inc., Piscataway, NJ) to 
obtain  the  mononuclear  cells.  When  this  procedure  was  carried  out  on  noninflamed 
synovial tissue, no mononuclear cells were obtained. 
Synovial Fluid Collection and Isolation  of Mononuclear Cells.  Synovial fluid from clini- 
cally tender and  swollen  knees was aspirated  under  aseptic conditions  with  a  2-gauge 
needle into a  sterile syringe. The fluid was maintained at room temperature and used 
within 3 h. The fluid was centrifuged and the cell pellet resuspended in PBS. These cells 
were centrifuged on FicolI-Paque gradients and the mononuclear cells collected from the 
interface were washed and resuspended in DMEM. The remaining cell-free synovial fluid 
was frozen at -20 °C until assayed for fibroblast-activating factor(s) (FAF). 
Peripheral Blood Mononuclear Cells.  50 ml of venous peripheral blood were obtained 
from adult patients with confirmed definite or classic rheumatoid arthritis or from normal 
volunteers, diluted in PBS, and layered on Ficoil-Paque gradients. After centrifugation, 
the interface containing the mononuclear cells was collected, washed, and resuspended at 
2 ×  106 cells/ml in DMEM. 
Identification of Cell Surface Antigens on Isolated Mononuclear Cells.  Direct immunoflu- 
orescence studies on isolated single-cell suspensions used fluorescein-conjugated monoclo- 
nal antibodies directed to a common cell surface antigen on human peripheral blood T 
cells (OKT3), to the helper/inducer T  cell subset (OKT4), to the suppressor/cytotoxic 
subset (OKT8), and to the HLA-DR antigen.  OKM1  was used in indirect immunofluo- 
rescence studies with a goat F(ab')2 anti-mouse IgG preparation conjugated with fluores- 
t Abbreviations used in this paper:  Con A, concanavalin A; DMEM, Dulbecco's modified Eagle's 
medium; FACS, fluorescence-activated cell sorter;  FAF, fibroblast-activating factor; FCS, fetal calf 
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cein isothiocyanate (Tago, Inc., Burlingame, CA).  Control antibody directed against an 
irrelevant antigen (mouse Thy-1.1; Becton, Dickinson & Co.) was also used to stain the 
cells.  The cells that were stained with experimental or control antibody were analyzed 
with a fluorescence-activated cell sorter (FACS II; B-D FACS Systems, Becton, Dickinson 
& Co.) for cell surface fluorescence as described (10). 
Mononuclear Cell Culture.  Mononuclear cells isolated from peripheral blood, synovial 
fluid or synovial tissue were suspended at 2 ×  106/ml in serum-free DMEM with antibiotics 
and glutamine. 1-ml aliquots were dispensed in TC24 culture dishes (Costar, Cambridge, 
MA).  When adequate numbers of synovial fluid mononuclear cells were available, sepa- 
ration of monocytes and lymphocytes was achieved by adherence. After a 1-2 h incubation 
of the mononuclear cells, the nonadherent cells were removed, leaving OKM 1  ÷ adherent 
macrophages (1 ×  108/ml) in the culture wells. The nonadherent OKT3  ÷ T  lymphocytes 
were pooled, resuspended, and cultured at  1 ×  106]ml in TC24 culture wells. To some 
cultures, concanavalin A (Con A) (Calbiochem-Behring Corp., La Jolla, CA) or lipopoly- 
saccharide (LPS) (E. coli 055:B5; Difco Laboratories, Inc., Detroit, MI) was added at the 
onset of culture. Culture plates were incubated at 37°C and the cell-free supernatants 
harvested at various time points up to 72 h. The supernatants were frozen at -20 *C until 
assayed in the fibroblast proliferation assay. 
Fibroblast Proliferation Assay.  Primary fibroblast cultures established in DMEM con- 
raining antibiotics, 2 mM glutamine, and 10% fetal calf serum (FCS) (Gibco Laboratories, 
Grand Island, NY) were used in a system previously shown (4) to be regulated by human 
mononuclear cell products. For proliferation assays (4), trypsinized fibroblasts were plated 
at 5 ×  104 cells per well in TC24 plates in 1 ml DMEM containing 10% FCS for 2-4 h, 
:washed,  and cultured overnight without serum. After removing the media, the synovial 
supernatants diluted in serum-free DMEM were added and cultures incubated 48 h before 
being pulsed  for 4  h  with  1 #Ci/ml tritiated  thymidine ([SH]TdR) (sp act,  6  Ci/mM; 
Schwarz/Mann Div.,  Becton, Dickinson & Co., Orangeburg,  NY).  Trypsinized cultures 
were harvested with an automated harvester and processed for determination of [3H]TdR 
incorporation. Units of FAF in the supernatant were calculated by comparing the [SH]- 
TdR uptake with a standard FAF supernatant prepared from Con A-stimulated human 
mononuclear cells arbitrarily defined as  100 U/ml.  FAF units were determined by the 
following formula:  [(reciprocal titer of test supernatant at  50%  maximum cpm of the 
standard) ×  100]/[reciprocal titer of the standard at 50% maximum cpm]. 
Sephacryl S-200 Gel Filtration.  After dialysis against Tris buffer, pH 7.5, the synovial 
cell supernatants were lyophilized and reconstituted in PBS. 1-ml samples of concentrated 
fluid were applied to a  1.0 ×  45 cm column of Sephacryl S-200 (Pharmacia, Inc.) which 
had been equilibrated with 0.15 M NaCI, 0.02 M phosphate buffer, pH 7.2. The void 
volume was determined with blue dextran and the column was calibrated with cytochrome 
c and ovalbumin (Pharmacia,  Inc.). The sample was  eluted with  PBS and the protein 
concentration of each fraction was determined by measuring the absorbance at 280 nm. 
Results 
Characterization  of Inflammatory  Cells  Within  the  Synovial  Tissue.  Diseased 
synovial tissues from 12 rheumatoid arthritis patients with active synovitis were 
obtained at arthroscopy.  Immunohistological evaluation of these diseased  syn- 
ovial  tissues  revealed  hyperplasia  of synovial  lining  cells and  the  presence  of 
mononuclear  inflammatory  cells  in  the  sublining  layer (Fig.  1 A).  Phenotypic 
analysis revealed that many of these cells were Leu-1 (pan-T cell)-positive cells 
(Fig.  1 B) and monocytes that stained with the OKM1 (Fig.  1 C) and Leu-M1 and 
Leu-M~  monoclonal antibodies  (not  shown).  Furthermore,  HLA-DR  antigens 
stained densely in synovial lining areas (Fig.  1 D) and also stained mononuclear 
cells in  the  sublining  layer (Fig.  1D).  Mononuclear  cells within  the  synovium 
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FIGURE  1.  Immunohistologic identification of synovial tissue mononuclear cells. Synovial 
tissue was fixed in formalin, sectioned, and stained with  hematoxylin  and eosin (A) or frozen, 
fixed in acetone, and immunoperoxidase-stained  using Leu-1 (B), OKM1 (C), or HLA-DR 
(D) monoclonal  antibodies. 
Release  of FAF by Cultured Synovial  Tissue  and Mononuclear  Cells.  To deter- 
mine whether the inflammatory cells within the synovial tissue produced FAF- 
like activity that  might account for the  hyperplasia of the synovial fibroblasts, 
250 mg of minced synovial tissue from the rheumatoid arthritis patients described 
above were cultured. Supernatants were harvested from the cultures at varying 
time periods and assayed for their ability to induce fibroblast growth. Superna- 
tants from  10  of  12  synovial tissue cultures  were  found to contain significant 
FAF (activity >10  U/ml)  (Fig.  2A).  No  exogenous stimuli were added  to  the 
synovial cultures; FAF-like activity was detected in the supernatants within 24 h 214  SYNOVIAL  FIBROBLAST-ACTIVATING FACTOR 
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FIGURE 2.  FAF activity in synovial biopsy cultures. ~250 mg of finely minced synovial tissue 
from joints with synovial inflammation (A) or noninflammatory  disease (B) were cultured in 
10 ml serum-free medium for 48 h. Supernatants were diluted and assayed for their ability to 
induce fibroblast [SH]TdR incorporation. [SH]TdR cpm were transformed into units of FAF 
by comparison with a standard FAF preparation containing 100 U/ml. 
and increased and plateaued by 72 h. In contrast, when synovial tissues obtained 
from individuals with noninflammatory  joint disease were processed in a similar 
manner, the supernatants from these cultures did not contain significant levels 
of FAF (Fig. 2B). 
Moreover, the mononuclear cells were isolated from the diseased rheumatoid 
synovial tissue, cultured at 2  ×  108 cells/ml, and the 48-h supernatants tested for 
FAF activity. Since these cells spontaneously generated substantial levels of FAF 
activity (Table I), the mononuclear cells were clearly a source of the FAF activity. 
With  no  in  vitro  stimulation,  synovial  tissue  mononuclear cell  supernatants 
contained  FAF  activity capable  of enhancing fibroblast  proliferation  50-fold 
above the levels of [3H]TdR incorporated in unstimulated fibroblast cultures. 
The  production  of this  activity could  not  be  attributed  to  activation  of the 
mononuclear cells by the collagenase or contamination of the collagenase with 
agents  such  as  endotoxin,  since  the  activity was  also  generated by  inflamed 
synovium before enzymatic digestion. The addition of LPS or Con A  to these 
cultures did not  enhance the maximum levels of FAF  activity already being 
produced, even when tested at lower dilutions. Thus, these cells appear to have 
been activated in vivo and continued to secrete mediators of fibrob!ast growth 
in vitro. Enzymatic digestion of synovial tissue from individuals with noninflam- 
matory joint disease yielded insufficient mononuclear cells for culture, and no 
FAF activity could be measured. 
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TABLE  I 
Stimulation of Fibroblast Proliferation by Synovial Tissue 
Mononuclear Cell Supernatants 
Stimulant  Fibroblast proliferation ([SH]TdR 
incorporation) 
cpm 
None*  11,040 ± 691' 
LPS  11,161 ± 251 
Con A  11,601 ± 808 
Control  246 ± 24 
* 2 x  l&/ml mononuclear cells obtained from synovial tissue were cul- 
tured without stimuli (none) or with 30 pg/ml LPS or 5 #g/ml Con A 
for 48 h, and the cell-free supernatants collected. 
* 5 x 104 fibroblasts were cultured with a 1  : 10 dilution of  the mononuclear 
cell supernatants  for 48  h.  The cultures were pulsed  with  1 pCi/ml 
[SH]TdR  for 4  h  and  processed  for the  determination  of [SH]TdR 
incorporation. Data represent the mean ± SE of triplicate cultures from 
a representative experiment. Control represents fibroblasts cultured in 
medium only. 
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FIGURE 3.  Sephacryl  S-200  chromatography of synovial  mononuclear cell supernatants. 
Concentrated (10x) supernatants were applied  to a calibrated  Sephacryl  S-200 column and 
eluted in PBS. Fractions  were assayed for their ability to induce fibroblast  [SH]TdR incorpo- 
ration. 
Stimulating Fibroblast Growth.  To determine whether the mediators of fibropla- 
sia  spontaneously  produced  by the  synovial  mononuclear  cells  were  similar  to 
those previously identified as peripheral  blood T  cell and monocyte products in 
vitro, preliminary characterization  of the supernatant  factors was initiated.  Two 
peaks of FAF activity were eluted from a  Sephacryl S-200 column (Fig.  3).  The 
first peak, eluting near 40,000 mol wt, was consistent with the product generated 
by peripheral  blood T  lymphocytes (4). A  second, smaller peak of activity, in the 216  SYNOVIAL  FIBROBLAST-ACTIVATING FACTOR 
15,000  mol  wt  range,  may  represent  the  monocyte product  that  has  been 
reported (6) to have both FAF and interleukin 1 activity, or another fibroblast 
growth factor. The evidence suggests that  the inflammatory lymphocytes and 
monocytes found  in  the  diseased  synovial  tissue  can  generate  mediators  of 
fibroblast growth that  have been shown to be produced by lymphocytes and 
monocytes stimulated in vitro. Studies are in progress to obtain sufficient quan- 
tities of these mediators for more definitive analysis. 
Identification of  Fibroblast Growth-promoting Activity in Synovial Fluid.  Synovial 
fluid obtained from adult patients with definite or classic  rheumatoid arthritis 
was centrifuged and the cell-free fluid was diluted and assayed for its effects on 
fibroblast proliferation. As is evident in Fig. 4, which is representative of synovial 
fluid from three patients, maximal activity was seen in diluted joint fluid, with 
inhibition at higher concentrations. Although the fibroblast growth-promoting 
activity titers were variable, 30 of 30 synovial fluids tested were found to contain 
significant levels of activity (>10  U/ml) with some of these fluids containing 
activity >600  U/ml.  In  preliminary experiments,  we  have  identified  similar 
activity in the synovial fluid of patients with psoriatic arthritis and inflammatory 
osteoarthritis, suggesting that the presence of fibroblast growth activity is not 
specific for rheumatoid arthritis but rather is associated with inflammation. Since 
it is difficult to dissociate the contribution of serum proteins and other factors in 
the synovial fluid, we focused on the isolation of inflammatory cells from the 
synovial fluid. 
Production  of FAF by Synovial  Mononuclear  Cells.  Mononuclear  cells  were 
isolated  from  synovial  fluid  to  determine  directly  whether  these  cells  were 
producing FAF and contributing to the fibroblast growth activity found in the 
synovial fluid. In addition, the isolated synovial mononuclear cells were stained 
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FIGURE 4.  Stimulation of fibroblast proliferation by synovial fluids. Synovial fluids obtained 
from three patients at arthrocentesis were centrifuged, diluted in DMEM  at the indicated 
concentrations, and  assayed for  their ability to  induce  flbroblast [SH]TdR  incorporation. 
Fibroblasts cultured in medium only incorporated <1,000 cpm. WAHL,  MALONE,  AND  WILDER  217 
directly with fluorescein-conjugated,  cell-specific monoclonal antibodies or indi- 
rectly with the monoclonal antibodies and fluorescein-labeled secondary antibod- 
ies,  and  analyzed  by  flow  microfluorometry  (FACS).  OKT3 ÷  T  lymphocytes 
were the predominant cell isolated from some patients; OKM 1 ÷ monocytes were 
the  majority  in others,  and equivalent  numbers  of OKT3 ÷ and OKM1 ÷ mono- 
cytes  were  also  observed.  Four  patients  are  represented  in  Table  II,  which 
demonstrates  the heterogeneity of these  mononuclear cell isolates.  Many of the 
cells were found to be HLA-DR-positive (Table  II), emphasizing their activated 
state in the inflammatory site.  The  mononuclear cells were cultured  serum-free 
at 2  ×  106 cells/ml for 48 h  with or without exogenous stimuli. The supernatants 
were  then  assayed for the  presence  of FAF activity.  As is evident  in Table  III 
and Fig. 5, supernatants  from synovial fluid mononuclear cells contained signif- 
icant FAF activity even in the absence of in vitro stimulation.  Limited enhance- 
ment  of activity  was  detected  if the  synovial  mononuclear  cells  were  further 
stimulated  in vitro with LPS or Con A  (Table  III). 
TABLE  II 
Phenotypes of Mononuclear Cell Populations in the Synovial Fluid of 
Rheumatoid Arthritis Patients 
Antibody 
Synovial fluid mononuclear cells* from patient: 
1  2  3  4 
OKT3  24~  61.2  40.0  56.9 
OKT4  13.9  40.3  35.8  32.7 
OKT8  8.5  23.7  14.3  29.2 
HLA-DR  68.1  42.7  47.7  44.7 
OKM1  71.2  24.1  47.2  39.8 
* Aliquots  of mononuclear cells isolated  from synovial fluid of four pa- 
tients  were stained  with the indicated  antibodies  and analyzed by flow 
microfluorometry for cell surface fluorescence.  Data represent the mean 
percent positive staining. 
TABLE  III 
Stimulation of Fibroblast Proliferation  by Synovial Fluid 
Mononuclear Cell Supernatants 
Fibroblast proliferation ([SH]TdR 
Stimulant  incorporation) 
cpm 
None*  4,612 :t: 577* 
LPS  6,386 :t: 551 
Con A  8,773 +  1,155 
Control  246 + 24 
* 2 X 10S/ml mononuclear cells obtained from synovial fluid were cultured 
without stimuli (none) or with 30 #g/ml LPS or 5 #g/ml Con A for 48 
h and the cell-free supernatants collected. 
* 5 x 104 fibroblasts were cultured with a 1:10 dilution of  the mononuclear 
cell supernatants  for 48  h. The cultures  were pulsed  with  1 #Ci/ml 
[SH]TdR  for 4  h  and processed  for the  determination  of [SH]TdR 
incorporation. Data represent the mean + SE of triplicate cultures from 
a representative experiment. Control represents  fibroblasts cultured in 
medium only. 218  SYNOVIAL  FIBROBLAST-ACTIVATING  FACTOR 
20 
18 
16  ? 
o 
x 
14 
Z 
O 
F-  12 
_z 
~  8 
I- 
I.- 
0 
• .  4 
t 
SYNOVIAL  BLOOD 
MNL  MNL 
FIGURE  5.  Spontaneous production  of FAF  activity  by synovial but  not peripheral blood 
e  mononuclear cells. 2 ×  10  mononuclear cells/ml obtained from joints with active inflammation 
or from peripheral blood were cultured for 48 h in the absence of serum or exogenous stimuli, 
and the supernatants tested for their ability to induce fibroblast [SH]TdR incorporation (cpm). 
Mononuclear cells were found in  very limited numbers or not at all in  the 
synovial fluid of patients with noninflammatory  joint disease or trauma, making 
it impossible to either characterize them or to culture them for FAF production. 
Thus, to compare the mononuclear cells from the inflamed synovium of arthritis 
patients  with a  noninflammatory mononuclear cell  population,  we compared 
mononuclear cells from the synovial fluid of patients with arthritis with mono- 
nuclear cells obtained from peripheral blood, for the production of FAF activity. 
Little or no FAF activity was detected in the supernatants of the peripheral blood 
mononuclear cells (2 x  106/ml) in the absence of in vitro stimulation, whereas 
substantial levels of FAF were seen in similar cultures of synovial mononuclear 
cells (Fig. 5). FAF activity could, however, be generated after stimulation of the 
peripheral blood cells with LPS or Con A  (4).  Thus,  in contrast to circulating 
peripheral blood lymphocytes and monocytes, cells isolated from inflamed syn- 
ovium  spontaneously  produced  significant  quantities  of this  mediator(s).  To 
determine whether the monocytes or the lymphocytes were the source of this 
fibroblast  growth  activity,  synovial  fluid  cells  were  separated  into  adherent 
OKM1 ÷  monocyte monolayers and  nonadherent  OKT3 +  cells.  Supernatants 
were collected from these cells and, as demonstrated in Fig. 6, both cell popula- 
tions released activity that could stimulate fibroplasia into their supernatants. WAHL,  MALONE,  AND  WILDER  219 
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FIGURE 6.  Spontaneous production of FAF activity by adherent and nonadherent synovial 
6  4-  mononuclear cells.  1  ×  106  OKM1 + or  1  ×  10  nonadherent OKT3  cells obtained from 
synovial fluid of joints with active inflammation were cultured for 48  h  in the absence of 
serum or exogenous stimuli, and the supernatants tested for their ability to induce fibroblast 
[SH]TdR incorporation (cpm). 
Discussion 
The  increased  proliferation  of synovial  lining cells occurring in association 
with the appearance  and  persistence of lymphocytes and  macrophages in the 
subsynovium is a well-recognized histological feature of both early and advanced 
rheumatoid arthritis. However, the immune reactions taking place in the synovial 
tissue in rheumatoid arthritis are poorly understood. 
By immunohistologic analysis, the mononuclear inflammatory cells within the 
inflamed tissue were identified as Leu-I+/OKT3 + T  lymphocytes and OKM1 +, 
Leu-M 1  ÷ macrophage-like cells. Consistent with previous studies (13-15),  Leu- 
3÷/OKT4 + lymphocytes predominated among the lymphocytes in these tissues, 
particularly  in  nodular  lymphocytic areas.  The  relatively  high intensity  anti- 
HLA-DR staining suggested that both the lymphocytes and macrophages were 
activated within the inflammatory locus (2,  16). These observations suggest that 
mechanisms similar to those operating in delayed-type hypersensitivity reactions 
are  involved  in  the  pathogenesis  of  rheumatoid  arthritis  (17).  When  these 
diseased synovial tissues were cultured in vitro and the supernatants assayed for 
their ability to induce fibroblast growth, significant FAF activity was measurable 
in the culture supernatants.  In the studies described here,  FAF activity refers 
only to the initiation of growth in quiescent fibroblast monolayers. In 10 of 12 
supernatant preparations, > 10 U  of FAF/ml were released within the first 24 h 
of culture.  Similar  preparations  of synovial  tissue  obtained  during corrective 
surgical procedures for noninflammatory joint disease did not release significant 
FAF activity into the culture supernatants,  emphasizing the inflammatory cell 
dependence of the generation of this mediator of fibroplasia. 
Since  the  diseased  synovial  tissue  was  a  major  source  of FAF-like  activity, 
experiments were subsequently initiated to determine which of the cells in the 
inflamed tissue were the source of this activity. After enzymatic digestion of the 
tissue and isolation of the mononuclear cells that were characterized as OKT3 ÷ 220  SYNOVIAL  FIBROBLAST-ACTIVATING FACTOR 
T  lymphocytes and OKM 1  + monocytes, cultures were established for mediator 
production.  Supernatants  from  unstimulated  cultures  contained  significant 
amounts of FAF-like activity. Attempts to enhance production of this mediator 
with Con A and/or LPS were ineffective, suggesting that the mononuclear cells 
were already maximally activated in vivo. The activity detected in the synovial 
cell supernatants shares the biological and physicochemical characteristics of the 
factor that is released by activated peripheral blood T  cells, with a  molecular 
weight near 40,000  (4), and also may represent interleukin  1 (15,000  mol wt), 
produced by  activated  monocytes in vitro  (6).  In additional  experiments,  the 
synovial mononuclear cells were separated into T  lymphocyte-enriched (OKT3 +) 
and adherent monocyte (OKM 1  +) populations. Both populations were the source 
of fibroblast growth activity. Thus, both T  cells and monocytes obtained from 
this  inflammatory  lesion  are  activated  in  vivo,  resulting  in  the  secretion  of 
mediators that can promote fibroblast growth. 
Further evidence that the synovial lymphocytes are activated in vivo has been 
previously demonstrated by  the  enhanced production of migration inhibition 
factor (18) and of lymphocyte blastogenic factor and immunoglobulins (19) in 
the synovial tissue of patients with rheumatoid arthritis. Mononuclear cells eluted 
from synovium also spontaneously secrete leukocyte migration inhibitor factor 
(LIF) (20). In addition to FAF, other mediators can be found within the synovial 
fluid of arthritis patients (21).  The monocyte-derived factor, interleukin  1, has 
also recently been identified in synovial effusions (22, 23). Although the signals 
leading to activation of the mononuclear cells are unknown, it appears that these 
cells are  triggered in vivo to generate  mediators associated with delayed-type 
hypersensitivity. 
As to the potential role of these mediators in the pathogenesis of rheumatoid 
arthritis,  it  is  likely  that  the  infiltrating  populations  of T  lymphocytes  and 
monocytes found in the rheumatoid synovium, activated by some yet unidenti- 
fied, but probably persistent stimulus, begin secreting lymphokines and mono- 
kines, including those that can  modulate fibroplasia.  The enhanced fibroblast 
numbers can,  in turn, generate elevated levels of inflammatory mediators and 
tissue-destructive enzymes. In addition to stimulating fibroblast growth, mono- 
nuclear cell factors (MCF, IL-1) can also regulate the production of prostaglan- 
dins and collagenase by synovial cells and fibroblasts (24-27).  Thus, the hyper- 
plasia of the synovial tissue, as well as the production and release of degradative 
enzymes that contribute to the perpetuation and tissue destruction characteristic 
of rheumatoid arthritis, may all be modulated by mononuclear cell signals. 
Summary 
A  characteristic feature of rheumatoid arthritis is hyperplasia of the synovial 
lining cells and fibroblasts, the source of tissue-degrading mediators, in associa- 
tion  with  the  appearance  and  persistence  of lymphocytes  in  affected joints. 
Diseased synovial  tissue  obtained  at  arthroscopy  from  10  of  12  rheumatoid 
arthritis patients was found to release a factor(s)  that could stimulate quiescent 
fibroblasts to proliferate in vitro.  Mononuclear cells isolated from this synovial 
tissue and from the synovial fluid spontaneously produced flbroblast-activating 
factor(s) (FAr).  In contrast, synovial tissue from patients with noninflammatory WAHL,  MALONE, AND  WILDER  221 
joint  disease  did  not  release  FAF.  By gel  filtration,  FAF  was  detected in  two 
peaks  (40,000  and  15,000  mol  we)  that  were  consistent  with  the  previously 
described peripheral blood T  lymphocyte- and  monocyte-derived factors with 
identical activity. The mononuclear cells were predominantly OKT3+/Leu-1 ÷ T 
lymphocytes and OKM 1  + cells of monocyte/macrophage lineage that expressed 
HLA-DR antigens, suggesting prior activation of these cells.  Mononuclear cells 
isolated from the peripheral blood of these patients did not spontaneously secrete 
FAF. Lymphocytes and monocytes from the site of synovial inflammation appear 
to be activated in situ to produce factors that may contribute to the hyperplasia 
and overgrowth of the synovial membrane in rheumatoid arthritis. 
We are indebted to Dr. Henry Roth for providing blood and synovial fluid samples, to 
Dr. Ildy Katona and Neil Hardegen for their contributions to this study, toJanice Benson 
Allen,  William  Helsel, and Jeffrey Finnegan  for excellent technical assistance,  and to 
Janice Forrest for her help in preparing the manuscript. 
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